Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studies

Citations Over Time

Abstract

Rewards and penalties, apparently arising from random variations, can affect regulatory decisions on the acceptance of IBE and can lead to incorrect conclusions.

Related Papers

• → Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing?(1996)60 cited
• Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.(1994)
• → Assessment of Key Pharmacokinetic Variables of Bioequivalent and Non-bioequivalent Enrofloxacin Preparations under Various Water Management Conditions(2010)5 cited
• Pharmacokinetic Evaluation of a Gastrointestinal Motility Tretment of Drug in Healthy Human Volunteers (Cinitapride)(2009)